Limitations of EBV-PCR monitoring to detect EBV associated post-transplant lymphoproliferative disorder

Pediatric Transplantation

Volumn 7, Issue 3, 2003, Pages 223-227

  Axelrod, David A ^a   Holmes, Ronald ^a   Thomas, Susan E ^a   Magee, John C ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

EBV; PCR; PTLD; Transplantation

Indexed keywords

ACICLOVIR; AZATHIOPRINE; BLEOMYCIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DOXORUBICIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PROCARBAZINE; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY; VINBLASTINE SULFATE; VINCRISTINE;

ACUTE KIDNEY TUBULE NECROSIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; GRAFT VERSUS HOST REACTION; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; INFANT; IRRITABILITY; KIDNEY TRANSPLANTATION; LABORATORY DIAGNOSIS; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; LYMPH NODE BIOPSY; LYMPHOPROLIFERATIVE DISEASE; POLYMERASE CHAIN REACTION; RECIPIENT; RELIABILITY; SURVIVAL RATE; VIRUS DETECTION; VIRUS INFECTION; VIRUS LOAD;

CHILD; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATIONS; VIRAL LOAD;

EID: 0037980065     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3046.2003.00080.x     Document Type: Article

References (19)

1. COLLINS MH, MONTONE KT, LEAHEY AM, et al. Post-transplant lymphoproliferative disease in children. Pediatr Transpl 2001: 5: 250-257.
2. NALESNIK MA. The diverse pathology of post-transplant lymphoproliferative disorders: the importance of a standardized approach. Transpl Infect Dis 2001: 3: 88-96.
3. ROWE DT, QU L, REYES J, et al. Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J Clin Microbiol 1997: 35: 1612-1615.
4. WAGNER HJ, WESSEL M, JABS W. Patients at risk for development of posttransplant lymphoproliferative disorder: plasma versus peripheral mononuclear cells as material for quantification of Epstein-Barr viral load by using real-time quantitative polymerase chain reaction. Transplantation 2001: 72: 1012-1019.
5. GREEN M, BUENO J, ROWE D, et al. Predictive negative value of persistent low Epstein-Barr virus viral load after intestinal transplantation in children. Transplantation 2000: 70: 593-596.
6. NIESTERS HG, VAN ESSER J, FRIES D, et al. Development of real-time quantitative assay for detection of Epstein-Barr virus. J Clin Microbiol 2000: 38: 712-715.
7. HOLMES, RD. SOKOL RJ. Epstein-Barr virus and post transplant lymphoproliferative disease. Pediatr Transpl 2002: 6: 456-464.
8. WINGEN A-M, WIESEL M, MOHRING K, SCHARER K, MAHIS O. Malignancies in children with renal replacement therapy. Transplant Proc 1994: 26: 5-6.
9. SRIVASTAVA T, ZWICK D, ROTHBERG PG, WARADY BA. Post-transplant lymphoproliferative disorder in pediatric renal transplantation. Pediatr Nephrol 1999: 13: 748-754.
10. HEBERT D, SULLIVAN EK. Malignancy and posttransplant lymphoproliferative disorder (PTLD) in pediatric renal transplant recipients: a report of the North American Pedatric Renal Transplant Cooperative Study (NAPRTCS) (Abstract). Pediatr Transpl 1998: 2 (Suppl.1): 57.
11. SHAPIRO R, SCANTLEBURY VP, JORDAN ML, et al. Pediatric renal transplantation under tacrolimus-based immunosuppression. Transplantation 1999: 67: 299-303.
12. REYES J, JAIN A, MAZARIEGOS G, et al. Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection. Transplantation 2000: 69: 2573-2580.
13. COX KL, LAWERNECE-MIYASAKI LS, GARCIA-KENNEDY R, et al. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation 1995: 59: 524-529.
14. GREEN M, REYES J, WEBBER S, ROWE D. The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplantation lymphoproliferative disease following solid organ transplantation. Transpl Infect Dis 2001: 3: 97-103.
15. ROWE DT, WEBBER S, SCHAUER EM, REYES J. GREEN M. Epstein-Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease. Transpl Infect Dis 2001: 3: 79-87.
16. McDIARMID SV, JORDAN S, KIM GS, et al. Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients. Transplantation 1998: 66: 1604-1611.
17. GREEN M, BUENO J, ROWE D, et al. Predictive negative value of persistent low Epstein-Barr virus viral load after intestinal transplantation in children. Transplantation 2000: 70: 593-596.
18. GREEN M, CACCIARELLI TV, MAZARIEGOS G, et al. Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for post-transplant lymphoproliferative disease. Transplantation 1998: 66: 1641-1644.
19. GREEN M, MICHAELS MG, WEBBER SA, ROWE D, REYES J. The management of Epstein-Barr virus associated post-transplant lymphoproliferative disorders in pediatric solid-organ transplant recipients. Pediatric Transpl 1999: 3: 271-281.